Telemedicine company TruClinic acquires Overl.ai to accelerate patient data entry with artificial intelligence
Release date: 2017-03-06 Recently, TruClinic announced the acquisition of Overl.ai, a medical artificial intelligence company headquartered in New York, USA. The parties did not disclose the transaction amount and acquisition method. TruClinic provides a secure network for healthcare professionals to implement telemedicine services. Users can remotely log in via mobile devices and desktop systems, allowing medical service providers and patients to connect remotely, enabling patients to receive adequate medical care and communication. Solutions include streamlining patient tracking, removing scheduling bottlenecks, increasing revenue for clinicians and increasing patient satisfaction. By acquiring Overl.ai, TruClinic will join the company's artificial intelligence products to improve patient data entry efficiency and solve data integration problems when connecting to Electronic Health Archives (EHR) to provide a better experience for users. “Providing an intuitive, user-friendly interface is essential for patients to use telemedicine access, while ensuring that the health care provider's workflow has not changed. These two factors are the reason for the acquisition.†TruClinic's CEO Justin Kahn said, “A meaningful work done by Overl.ai is to create a flexible and interactive solution for healthcare entities whose expertise and functionality are key to future telemedicine success.†Founded in 2014, Overl.ai designed an automated solution for patient data entry that combines machine learning and automated data capture to enhance the patient experience. Overl.ai's solution can be deployed on multiple platforms (network, tablet, mobile) and supports multiple languages. It captures clinical and non-clinical information, handles insurance eligibility, processes payments, schedules and confirms appointments, collects access surveys, and shares information in real time in the EHR system. “TruClinic is an excellent, lightweight, and powerful telemedicine platform that has been proven in the largest telemedicine system in the United States,†said Alex Zoller, CEO of Overl.ai. “By combining our technology and team Our current job is to provide a complete virtual access experience, from patient management, virtual clinics to virtual visits. Patients will no longer need to go to the medical institution for routine and follow-up visits, and the hospital will receive new tools. Provide patients with efficient and quality care. About TruClinic TruClinic was founded in 2010 and is headquartered in Salt Lake City, USA. Founders include Justin Kahn, John Walker, Michael Feldman and John Bolinder, which provide telemedicine services. Health Magazine, published in January 2017, selected it as the 2016 Digital Healthcare TOP 100 company. Since its inception, TruClinic has received a total of five investments, including a total of $476,400. About Overl.ai Founded in January 2014, Overl.ai is headquartered in New York and its founders include Gilbert Leistner, Vitaly Leokumovich, Alex Zoller, and Vitaly Leokumovich. Through artificial intelligence, the company enables healthcare organizations to provide medical services and patient telecommunications through their applications and web services. The company received a total of three investments, of which the seed round revealed $137,500. Source: Arterial Network
Point Of Care Testing POCT
GENEDIAN
iRapid 4 POC RT-PCR Detection System is a fully automatic integrated system
with simplified operation, easy to achieve "rapid read results",
fully enclosed detection, safe and pollution-free features. Configured with
GENEDIAN POC SARS-CoV-2 Nucleic Acid Detection Kit, the 4-well system is able
to run independently as well as run four different parameters at the same time.
Pcr System,Pcr Detection System,Real Time Pcr System,Quantitative Pcr Detection System HANGZHOU DIAN BIOTECHNOLOGY CO., LTD. , https://www.dianbiotech.com